Guggenheim Capital’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,984
| Closed | -$9K | – | 3097 |
|
|
2016
Q3 | $9K | Buy |
1,984
+1,038
| +110% | +$4.71K | ﹤0.01% | 2866 |
|
|
2016
Q2 | $9K | Hold |
946
| – | – | ﹤0.01% | 2854 |
|
|
2016
Q1 | $11K | Buy |
946
+467
| +97% | +$5.43K | ﹤0.01% | 2871 |
|
|
2015
Q4 | $7K | Hold |
479
| – | – | ﹤0.01% | 2958 |
|
|
2015
Q3 | $8K | Buy |
479
+60
| +14% | +$1K | ﹤0.01% | 2935 |
|
|
2015
Q2 | $8K | Hold |
419
| – | – | ﹤0.01% | 3024 |
|
|
2015
Q1 | $8K | Buy |
419
+108
| +35% | +$2.06K | ﹤0.01% | 3022 |
|
|
2014
Q4 | $9K | Buy |
+311
| New | +$9K | ﹤0.01% | 2986 |
|
|
2014
Q3 | – | Sell |
-569
| Closed | -$25K | – | 3234 |
|
|
2014
Q2 | $25K | Sell |
569
-57
| -9% | -$2.5K | ﹤0.01% | 3105 |
|
|
2014
Q1 | $31K | Buy |
626
+142
| +29% | +$7.03K | ﹤0.01% | 3136 |
|
|
2013
Q4 | $18K | Buy |
484
+29
| +6% | +$1.08K | ﹤0.01% | 3078 |
|
|
2013
Q3 | $47K | Sell |
455
-58
| -11% | -$5.99K | ﹤0.01% | 2880 |
|
|
2013
Q2 | $39K | Buy |
+513
| New | +$39K | ﹤0.01% | 2850 |
|